Skip to main content

Sepsis

February 05, 2025

Viewpoints Series: Enhancing Sepsis Care Across the Patient Journey 

A recent survey by bioMérieux and The UK Sepsis Trust found that while 95% of clinicians identify sepsis as a serious condition, 66% agree there is sometimes a delay in diagnosis in the hospital where they work. 

  • January 08, 2025

    Management and outcomes in pulmonary arterial hypertension patients with sepsis

    A recent retrospective study examining sepsis treatment in patients with and without pulmonary arterial hypertension (PAH) reveals critical insights for clinical practice.
  • September 12, 2024

    Do you have what it takes to be a Game Changer in the fight against infectious diseases and AMR?

    Play MICROBE LEAP, bioMérieux’s interactive AMS game, to test your diagnostic knowledge and antimicrobial stewardship skills as a Patient Protector or Resistance Avenger!
  • August 13, 2024

    Challenges in Sepsis Management  in Low and Middle Income Countries (LMICs)

    Delve into the critical challenges of sepsis management in resource-limited settings with Professor Machado's insightful interview.

  • June 03, 2024

    Evaluating the Impact of Source-Specific Order Sets for Sepsis on Empiric Antibiotic Selection in the Emergency Department

    A study shows source-specific antibiotic order sets in emergency care improve empiric treatment decisions for sepsis and support timely patient management.
  • November 23, 2023

    Clinical and Health Inequality Risk Factors for Non-COVID-Related Sepsis During the Global COVID-19 Pandemic

  • September 04, 2023

    Inside the Research: Studying Adherence to Sepsis Care Bundles Alongside The UK Sepsis Trust

    A new study with the UK Sepsis Trust explores barriers to sepsis care bundle adherence in Europe and offers insights to improve sepsis management strategies.
  • March 06, 2023

    Effect Of Intrapartum Azithromycin Vs Placebo On Neonatal Sepsis And Death: A Randomized Clinical Trial

    A clinical trial in West Africa tests whether intrapartum azithromycin reduces neonatal sepsis and mortality, with additional evaluation of infection and fever rates.
  • June 14, 2022

    The Sepsign Trial For Early Detection Of Sepsis

    The SepSIGN trial aims to validate biomarkers that help predict early clinical worsening in adults admitted to the ED with suspected or confirmed infection.
  • February 14, 2022

    Hematopoietic Stem And Progenitor Cells Improve Survival From Sepsis By Boosting Immunomodulatory Cells

  • January 03, 2022

    Sepsis And Opioid Use Disorder: The Intersection Of Two Public Health Crises

    Sepsis linked to opioid use is an overlooked crisis driving hospitalizations and harm, with experts urging strategies to address this growing public health issue.
  • December 08, 2021

    Nailing The Culprit Quickly: Syndromic Testing For Bloodstream Infection And Sepsis

  • December 05, 2021

    Bacterial Toxins And Advances In Detecting Bloodstream Infections

  • October 03, 2021

    Surviving Sepsis Campaign: 2021 Guidelines Infographic

    The Surviving Sepsis Campaign infographic highlights updated global guidelines on antibiotic timing, vasoactive agents, and septic shock care.
  • September 13, 2021

    Assessment Of Sepsis And Acute Kidney Injury: Sepsis Alliance Summit

    Balancing timely sepsis treatment with AKI risk, experts highlight how early biomarker assessment can guide safer, more effective antimicrobial use.
  • August 29, 2021

    September Is Sepsis Awareness Month

    September is Sepsis Awareness Month, with resources and tools to help individuals and healthcare teams raise awareness and improve patient outcomes.
  • July 11, 2021

    Coronavirus Disease 2019 As Cause Of Viral Sepsis: A Systematic Review And Meta-analysis

    A systematic review shows COVID-19 ICU patients often meet sepsis criteria, highlighting the need for targeted treatments and policies for future pandemics.
  • May 10, 2021

    Every Minute Counts: Opportunities For Faster Blood Culture Results

  • February 22, 2021

    Biomarker-enhanced Clinical Assessment Of Sepsis And AKI

  • November 03, 2020

    Interpreting Procalcitonin In The New Cap Guidelines

    A podcast explores how new CAP guidelines view procalcitonin use alongside clinical judgment to guide antibiotic decisions in sepsis and respiratory care.